NH SPAC 2 (206640) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.000x

Based on the latest financial reports, NH SPAC 2 (206640) has a cash flow conversion efficiency ratio of 0.000x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩111.38 Million ≈ $75.48K USD) by net assets (₩237.02 Billion ≈ $160.62 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

NH SPAC 2 - Cash Flow Conversion Efficiency Trend (2015–2024)

This chart illustrates how NH SPAC 2's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read 206640 liabilities breakdown for a breakdown of total debt and financial obligations.

NH SPAC 2 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of NH SPAC 2 ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
Bank Ganesha Tbk PT
JK:BGTG
-0.087x
Chia Chang Co Ltd
TW:4942
-0.006x
Mpact Limited
JSE:MPT
-0.008x
New England Realty Associates LP
NYSE MKT:NEN
-0.034x
The Pinkfong Company
KQ:403850
0.052x
Arman Financial Services Limited
NSE:ARMANFIN
0.093x
Wallix Group SA
PA:ALLIX
0.192x
Equity Commonwealth
NYSE:EQC
0.127x

Annual Cash Flow Conversion Efficiency for NH SPAC 2 (2015–2024)

The table below shows the annual cash flow conversion efficiency of NH SPAC 2 from 2015 to 2024. For the full company profile with market capitalisation and key ratios, see market cap of NH SPAC 2.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2024-12-31 ₩223.05 Billion
≈ $151.16 Million
₩24.88 Billion
≈ $16.86 Million
0.112x -35.80%
2023-12-31 ₩197.42 Billion
≈ $133.79 Million
₩34.30 Billion
≈ $23.24 Million
0.174x +23.18%
2022-12-31 ₩163.56 Billion
≈ $110.84 Million
₩23.07 Billion
≈ $15.63 Million
0.141x -57.32%
2021-12-31 ₩151.09 Billion
≈ $102.39 Million
₩49.93 Billion
≈ $33.83 Million
0.330x -11.28%
2020-12-31 ₩119.86 Billion
≈ $81.23 Million
₩44.64 Billion
≈ $30.25 Million
0.372x +58.88%
2019-12-31 ₩73.55 Billion
≈ $49.84 Million
₩17.24 Billion
≈ $11.68 Million
0.234x +188.18%
2018-12-31 ₩65.33 Billion
≈ $44.27 Million
₩5.31 Billion
≈ $3.60 Million
0.081x +522.67%
2017-12-31 ₩67.87 Billion
≈ $46.00 Million
₩886.74 Million
≈ $600.93K
0.013x -91.67%
2016-12-31 ₩75.17 Billion
≈ $50.94 Million
₩11.79 Billion
≈ $7.99 Million
0.157x -3.10%
2015-12-31 ₩59.50 Billion
≈ $40.32 Million
₩9.63 Billion
≈ $6.53 Million
0.162x --

About NH SPAC 2

KQ:206640 Korea Medical Devices
Market Cap
$169.86 Million
₩250.65 Billion KRW
Market Cap Rank
#17145 Global
#772 in Korea
Share Price
₩11690.00
Change (1 day)
-0.76%
52-Week Range
₩10510.00 - ₩18040.00
All Time High
₩36222.75
About

Boditech Med Inc. offers instruments and diagnostic reagents in South Korea and internationally. The company offers instruments, including ichroma II, diagnostic immuno-analyzer to measure the presence of various biomarkers for cardiac, cancer, hormones, infectious diseases, autoimmune diseases, and metabolic diseases; ichroma III, a high-throughput immuno-analyzer that enables simultaneous testi… Read more